Literature DB >> 17106716

Antigen-independent immune responses after dendritic cell vaccination.

Nicolai Leonhartsberger1, Reinhold Ramoner, Thomas Putz, Hubert Gander, Andrea Rahm, Claudia Falkensammer, Georg Bartsch, Martin Thurnher.   

Abstract

The ability of cultured, antigen-loaded dendritic cells (DCs) to induce antigen-specific T cell immunity in vivo has previously been demonstrated and confirmed. Immune monitoring naturally focuses on immunity against vaccine antigens and may thus ignore other effects of DC vaccination. Here we therefore focused on antigen-independent responses induced by DC vaccination of renal cell carcinoma patients. In addition to the anticipated response against the vaccine antigen KLH, vaccination with CD83(+) monocyte-derived DCs resulted in a strong increase in the ex vivo proliferative and cytokine responses of PBMCs stimulated with LPS or BCG. In addition, LPS strongly enhanced the KLH-induced proliferative and cytokine response of PBMCs. Moreover, proliferative and cytokine responses of PBMCs stimulated with the homeostatic cytokines IL-7 and IL-15 were also clearly enhanced after DC vaccination. In contrast to LPS induced proliferation, which is well known to depend on monocytes, IL-7 induced proliferation was substantially enhanced after monocyte depletion indicating that monocytes limit IL-7 induced lymphocyte expansion. Our data indicate that DC vaccination leads to an increase in the ex vivo responsiveness of patient PBMCs consistent with a DC vaccination induced enhancement of T cell memory. Our findings also suggest that incorporation of bacterial components and homeostatic cytokines into immunotherapy protocols may be useful in order to enhance the efficacy of DC vaccination and that monocytes may limit DC vaccination induced immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106716     DOI: 10.1007/s00262-006-0245-4

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  6 in total

1.  Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.

Authors:  Susanne M Rittig; Maik Haentschel; Katrin J Weimer; Annkristin Heine; Martin R Muller; Wolfram Brugger; Marius S Horger; Olga Maksimovic; Arnulf Stenzl; Ingmar Hoerr; Hans-Georg Rammensee; Tobias A W Holderried; Lothar Kanz; Steve Pascolo; Peter Brossart
Journal:  Mol Ther       Date:  2010-12-28       Impact factor: 11.454

2.  Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis.

Authors:  Mehran Habibi; Maciej Kmieciak; Laura Graham; Johanna K Morales; Harry D Bear; Masoud H Manjili
Journal:  Breast Cancer Res Treat       Date:  2008-04-20       Impact factor: 4.872

3.  Low dose IL-15 induces snap arming of CD44(low) T lymphocytes in the absence of antigen.

Authors:  David L Tamang; Bryce N Alves; Viki Elliott; Stephanie A Fraser; Doug Redelman; Dorothy Hudig
Journal:  Cell Immunol       Date:  2008-05-16       Impact factor: 4.868

4.  Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters.

Authors:  Erik H J G Aarntzen; I Jolanda M de Vries; Joop H Göertz; Marjo Beldhuis-Valkis; Huberdina M L M Brouwers; Mandy W M M van de Rakt; Renate G van der Molen; Cornelis J A Punt; Gosse J Adema; Paul J Tacken; Irma Joosten; Joannes F M Jacobs
Journal:  Cancer Immunol Immunother       Date:  2012-04-21       Impact factor: 6.968

5.  Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.

Authors:  Florian Wimmers; Nienke de Haas; Anja Scholzen; Gerty Schreibelt; Elles Simonetti; Marc J Eleveld; Huberdina M L M Brouwers; Marjo Beldhuis-Valkis; Irma Joosten; Marien I de Jonge; Winald R Gerritsen; I Jolanda M de Vries; Dimitri A Diavatopoulos; Joannes F M Jacobs
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

6.  Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma.

Authors:  Gennadi Tulchiner; Renate Pichler; Hanno Ulmer; Nina Staudacher; Andrea Katharina Lindner; Andrea Brunner; Bettina Zelger; Fabian Steinkohl; Friedrich Aigner; Wolfgang Horninger; Martin Thurnher
Journal:  Cancer Immunol Immunother       Date:  2021-02-28       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.